INTRODUCTION
Methylation at the 5-positon of cytosine (5-mC), which is catalyzed by DNA methyltransferases (DNMTs), plays important roles in mammalian neuronal systems (1) . The proper establishment of DNA methylation is critical for embryonic and postnatal development (2, 3) . DNMT3a is required for maintaining neural stem cell self-renewal, and loss of the protein significantly impairs postnatal neurogenesis (4) , suggesting a regulatory role of DNA methylation in neurodevelopmental process (5) . Dnmt1 and Dnmt3a depletion induces abnormal neuronal phenotypes, including learning and memory deficits and abnormal synaptic plasticity (6) . Furthermore, pharmacological inhibition of Dnmt activity can block hippocampus-dependent memory formation (7) . Mutation of methyl-CpG binding protein 2 (MECP2), which binds to methylated DNA and acts as a transcriptional repressor or activator, causes Rett syndrome, and related neurodevelopmental disorders (8) . These observations indicate that the proper establishment and maintenance of DNA methylation are essential for normal development and function of the mammalian brain.
5-Hydroxymethylcytosine (5-hmC), which is converted from 5-mC by ten-eleven translocation (TET) proteins, is present in the mammalian genome (9 -11) . All TET family proteins can catalyze the conversion of 5-mC to 5-hmC.
TET1 was first reported to have a role in maintaining the pluripotent state of embryonic stem cells (ESCs) (12) , and together with TET2, it also regulates the cell lineage commitment of ESCs (13) . TET2 modulates the balance between self-renewal and differentiation in hematopoietic stem cells, making them critical for normal myelopoiesis; TET2 mutations are seen in multiple types of leukemia (14) (15) (16) (17) (18) . TET3 contributes to the global DNA methylation erasure during the zygote stage of embryonic development (19, 20) . Taken together, these studies point to a critical role of TET-mediated 5-hmC modification in developmental processes and the possibility that dysregulation of 5-hmC may be associated with disease.
Although DNA methylation has generally been regarded as a highly stable epigenetic mark, recent studies have uncovered DNA methylation changes during brain development and aging, suggesting that epigenetic changes like 5-mC could function as an intermediate step for the internal or external environmental regulation of the brain genome. Studies from our own and other groups have identified strong enrichment of 5-hmC in mammalian brains (9, 10, 21) . However, compared with 5-mC, little is known about the roles of 5-hmC in the mammalian brain. Our previous study revealed the dynamics of DNA hydroxymethylation during postnatal development and ageing in mouse brain (21, 22) . Another study found that 5-hmC is enriched at promoters and gene bodies, and its enrichment on gene bodies is positively correlated with gene expression in the frontal lobe tissue of human brain (23) . Nevertheless, the features of 5-hmC during human brain development remain a mystery.
Here, we extend our previous work to profile the genomewide distribution of 5-hmC during cerebellum development in human fetal and adult brains. We find that the overall 5-hmC level increases during cerebellum development. Most differentially hydroxymethylated regions (DhMRs) between the fetus and the adult overlap with genes, and are strongly associated with CpG island shores. Strikingly, these 5-hmC changes are highly enriched in genes whose transcripts can be regulated by fragile X mental retardation protein (FMRP), as well as in many genes linked with autism.
RESULTS

Dynamics of DNA hydroxymethylation and its genomic features in the human cerebellum
Previous studies indicated that 5-hmC levels in the mouse cerebellum are high and can change during developmental processes (10, 21) . To extend this work, here we focused on the human cerebellum to study the features of 5-hmC in the developing human brain. We first performed 5-hmC-specific dot blot with fetus and adult cerebellum DNA samples, and found that the total levels of 5-hmC increased significantly (42.1% increase) from the fetus to the adult stage ( Fig. 1A and B), consistent with the observation in mouse cerebellums.
To profile the genome-wide distribution of 5-hmC in the human cerebellum, we isolated genomic DNA containing 5-hmC using a chemical capture technique developed previously (22) and then sequenced those DNA fragments. A genome-wide correlation analysis showed that the 5-hmC profiles from two adult cerebellums are more similar to each other than either is to the fetal cerebellum (Fig. 1C) . We then determined the genomic features associated with 5-hmC-enriched regions and found that 5-hmC is highly enriched at genes (Supplementary Material, Fig. S1 ), particularly 5 ′ -UTR and exons, but it is depleted at introns and intergenic regions in both the fetal and adult samples (Fig. 1D) . Furthermore, 5-hmC is strongly associated with CpG islands and CpG island shores (P , 0.001, comparing observed and expected frequencies) (Fig. 1E) . Together, these data suggest that 5-hmC is significantly increased during the development of the human cerebellum and is associated with specific genomic regions.
5-hmC genomic features during cerebellum development
To examine the genomic features of 5-hmC during the development of the human cerebellum, we used a Poisson-based model calling method to determine the fetus-specific DhMRs (fetus has higher 5-hmC levels than adult) and adult-specific DhMRs (adult has higher 5-hmC levels than fetus). Across the genome, we identified 28 015 DhMRs between the fetus and adult samples, of which 15 829 are adult-specific and 12 186 are fetus-specific DhMRs ( Fig. 2A) . Hierarchical clustering of the top 500 most significant DhMRs indicated a greater similarity between adult samples, and a significant difference between the fetus and the adult, most showing an increase of 5-hmC levels in adult (Fig. 2B) . We noted that the fold-change of adult-specific DhMRs is much greater than fetus-specific DhMRs (Fig. 2C) . The majority of DhMRs we identified also showed a strong bias towards CpG islands and CpG island shores (P , 0.001) ( Fig. 2D and E) . Fetusspecific DhMRs had a stronger tendency to be associated with CpG islands (10.4 versus 5.2%) and CpG shores (22 versus 14%) than adult-specific DhMRs. Furthermore, both fetus-and adult-specific DhMRs overlapped more with CpG shores than with CpG islands (Fig. 2D and E) .
To examine the potential relationship between DhMRs and gene function, we aligned the identified DhMRs to the annotated human genes and found that 69% (8,407) of fetusspecific DhMRs overlapped with genes ( Fig. 3A) and 72% (11,396) of adult-specific DhMRs overlapped with genes ( Fig. 3B ). Both the fetus-specific and adult-specific DhMRs are also largely localized to UTR and exons, but are depleted at introns and intergenic regions ( Fig. 3C and D) . A similar pattern has been seen in DhMRs identified in mouse cerebellum (21) . Intriguingly, the fetus-specific DhMRs are more strongly associated with transcription start sites (TSS) than the adult-specific DhMRs (Fig. 3C and D) . Furthermore, around half of the genes associated with DhMRs also show differential hydroxymethylation during cerebellum development in mouse (observed-to-expected ratio: 1.45, 3.46 and 6.83 for genes that are associated with at least 1, 2 and 4 DhMRs) (Fig. 3E ). Gene ontology (GO) analysis indicated that the adult-specific DhMRs are enriched at genes involved in ion channel binding and cell -cell adhesion, and the fetusspecific DhMRs preferentially localize at genes associated with the ion channel and neuronal development (Supplementary Material, Fig. S2A and B). Figure 3E shows DhMRs in two genes, MYOD1 and MAP1B, both of which encode proteins involved in neuronal function.
Human Molecular
The fetus-specific DhMRs displays pluripotent epigenetic memories
Epigenetic properties of human ESCs dictate proper fetal development, and presumably, hESCs share more epigenetic features with the fetus than with the adult (24, 25) . Previous studies have also found 5-hmC enriched at genes in hESCs (26, 27) . We compared 5-hmC profiling between H1 hESCs and human cerebellum, and found that 5-hmC is dramatically depleted at TSS in human brain relative to ESCs, but still, retain a bimodal distribution (Fig. 4A) . Moreover, 5-hmC exhibits less enrichment at CpG islands and shores in human brain than in hESCs ( Fig. 4B-D) . These results indicate that the genomic distribution of 5-hmC has a different pattern in human brain, consisting mainly of post-mitotic cells, proliferating hESCs.
We next compared DhMRs identified in human brain with H1 ESCs 5-hmC enrichment peaks that we previously identified (28) . We found that 57% of fetus-specific DhMRs were shared with hESCs, but only 19% of adult-specific DhMRs were found in hESCs (Fig. 4E) . Furthermore, 338 of the 500 most highly enriched fetus-specific DhMRs were shared with ESCs while only 146 of the 500 most highly enriched adult DhMRs occurred in ESCs (Fig. 4F ). These data indicate that the fetus shares more epigenetic memory with ESCs than does the adult; this could play a role in development-specific gene expression, as suggested by the GO analysis of fetusspecific DhMRs described above. 
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DhMRs are associated with genes involved in neurodevelopmental disorders DNA methylation-mediated epigenetic modulation plays important roles in neurodevelopment. Dysregulation of DNA methylation can cause disorders such as Rett syndrome and fragile X syndrome (FXS) (1, 29, 30) . Recent studies have revealed 5-hmC-mediated epigenetic dynamics during embryonic (19, 20) and postnatal development (21) , which indicates a potential function for 5-hmC in development and disease (31) . More interestingly, both loss-and over-expression of MeCP2 not only affects the overall level of 5-hmC, but also modulates its distribution in the genome during mouse cerebellum development (21) . These studies pointed out to a potential role of 5-hmC in neurodevelopmental disorders.
To better understand the roles of 5-hmC in neurodevelopmental disorders, here we asked whether 5-hmC-enriched regions we identified were associated with neurodevelopmental disorders such as FXS, and more broadly, autism spectrum disorder (ASD). We first compared 5-hmC enrichment on all UC Santa Cruz (UCSC) RefSeq genes and FMRP target genes that were identified previously (32); FMRP targets displayed more 5-hmC enrichment than the RefSeq genes (Fig. 5A) . We then stratified the RefSeq genes into three groups: highly, moderately and weakly expressed genes based on the RNA expression level in the human cerebellum. FMRP target genes displayed more 5-hmC enrichment than any of the three groups (P , 0.001, Wilcoxon rank test). To rule out the possibility that enrichment of hydroxymethylation in FMRP target genes is a general characteristic of RNA binding proteins in cerebellum, we also looked at TAR DNA-binding protein 43 (TDP-43), which is involved in pre-mRNA splicing and translational regulation of its RNA ligand. Compared with FMRP target genes, we did not see strong 5-hmC enrichment in TDP-43 target genes (Fig. 5A) . We then analyzed 5-hmC mapping reads on all RefSeq genes, highly expressed genes, TDP-43 target genes and FMRP target genes and found 5-hmC showed higher mapping reads on FMRP target genes in both fetus and adult brain versus all other groups (P , 0.001, Wilcoxon rank test) (Fig. 5B and C) . Moreover, DhMRs also had a stronger tendency to localize on FMRP target genes than any other group (Fig. 5D and E) .
FXS is one of the leading monogenic causes of ASD, with up to 30% of FXS patients showing autistic symptoms. Two recent studies found an unusual coincidence between autismrelated genes and FMRP target genes, which had more than expected de novo mutations in children with ASD (32,33). Since we saw that 5-hmC significantly overlaps with FMRP target genes, we suspect that 5-hmC could also overlap more broadly with ASD genes. To examine this possibility, we investigated 190 autism candidate genes from the Simons Foundation Autism Research Initiative (SFARI) database (as of October 2011). Even though most of the FMRP target genes and autism candidate genes are associated with synaptic functions, in contrast to FMRP target genes, we did not see 5-hmC preferentially enriched in these autism candidate genes. However, consistent with FMRP target genes, we observed that the identified DhMRs between the fetus and the adult were enriched more (P , 0.001, Wilcoxon rank test; and observed-to-expected ratio, 1.65) in autism candidate 
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genes relative to all RefSeq genes ( Fig. 6A and B) . The enrichment is also true when the 190 candidate genes were grouped into highly expressed genes, moderately expressed genes and weakly expressed genes (Fig. 6C) . To further examine this correlation, we focused on the 22 syndromic genes and 21 strong candidate and suggestive genes linked to autism in the SFARI database. We found that both the total counts and DhMRs of 5-hmC are enriched in some autism syndromic genes including CACN1C, SHANK3 and TSC2 (Supplementary Material, Fig. S3A and C) as well as strong candidate and suggestive genes including CACNA1H, ATP10A and OXTR (Supplementary Material, Fig. S3B and D) . Importantly, DhMRs significantly overlap with strong candidate and suggestive genes (observed-to-expected ratio, 1.52). Taken together, these results indicate that both stable and dynamic 5-hmC strongly associated with FMRP target genes, and 5-hmC changes are associated with autism genes. Our results suggest that dysregulation of 5-hmC could be a potential contributor to the pathogenesis of neurodevelopmental disorders.
DISCUSSION
Previous studies have shown that 5-hmC is enriched in the mammalian brain (10, 21, 23) , and its levels vary in different tissues (34) (35) (36) (37) . However, the genomic features of 5-hmC modification during the development of human brain are still unknown. To explore this, we profiled 5-hmC at a genomewide level in fetal and adult human brain and found that 5-hmC is increased during the development of human cerebellum, suggesting strong DNA hydroxymethylation dynamics in this brain region. In our previous study, we have discovered that 5-hmC displays dynamics during the postnatal development of mouse brain (21) . Together with this finding, our current results suggest that 5-hmC-mediated epigenetic pathways might play evolutionarily conserved roles in the mammalian brain. Compared with other brain regions, the cerebellum displays a distinct pattern of both DNA methylation and gene expression (38 -40) . The differences between the cerebellum and other brain regions may be partially attributable to cerebellum Purkinje neurons, which are considered a primary organizer in the development of the cerebellum. Purkinje neurons exhibit a greater proportion of 5-hmC versus other types of neurons. Therefore, the cerebellum may be a specific brain region susceptible to 5-hmC changes partially through Purkinje neurons.
DNA methylation is considered a relatively stable epigenetic mark compared with histone modifications. During the last several years, DNA methylation signature was found to show certain dynamics associated with brain development and aging. Since most approaches assessing DNA methylation levels cannot distinguish hydroxymethylation from methylation, the extent to which hydroxymethylation contributes to previously discovered methylation dynamics remains unknown. Our results suggest that, at least in the cerebellum, 5-hmC levels also change dramatically. In particular, some of the 5-hmC dynamically modified genes, such as MYOD1, have been reported to be associated with methylation dynamics during brain development and the aging process (39, 40) . It is likely that 5-hmC, together with 5-mC, acts as an 
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Human Molecular Genetics, 2012, Vol. 21, No. 26 intermediate step for upstream regulators to regulate these gene expression changes. 5-hmC is abundant in hESCs and brain regions, and the genomic features of 5-hmC in hESCs are well characterized (28, 41) . Similar to hESCs, in cerebellum, 5-hmC displayed a bimodal distribution around TSS and was enriched in gene body regions. Interestingly, compared with hESCs, we found less 5-hmC at CpG islands and CpG shores, suggesting that CpG islands and shores may have a specific protective mechanism against 5-hmC modification in cerebellum. Furthermore, we find that 5-hmC changes tend to occur more often outside of CpG islands (more likely to occur in CpG island shores than islands). This observation is also consistent with DNA methylation dynamics being seen most often occurring outside of CpG island regions during early brain development and aging, as well as tissue and cancer differences (42, 43) . For example, Numta et al. showed that DNA methylation changes associated with developmental and aging processes in the prefrontal cortex are more likely to occur outside of CpG islands (43) .
Neurodevelopmental disorders, such as ASD, usually present years after birth. However, the molecular pathogenesis is thought to occur early during pregnancy or around birth. Consistent with the finding that DNA methylation changes in the brain during early life stages, we found that 5-hmC also shows a positive correlation with cerebellum development both in the mouse and in the human. The cerebellum of the human brain plays an important role in motor control as well as motor learning. In additional to this well-established role, there has been a growing recognition that the cerebellum is also involved in cognitive functions such as attention and language, and emotional control, such as fear and pleasure responses (44, 45) . Our findings in human cerebellum could have further implications for 5-hmC in the pathogenesis of neurodevelopmental disorders, which are associated with cognitive impairment, stereotypic movement, etc. Our earlier (21) . In the present study, we have gained several new insights. We find that FMRP target genes are highly enriched with 5-hmC modifications and subject to changes during cerebellum development. This observation may be unique to FMRP target genes, since we did not see 5-hmC enrichment in the targets of other RNA binding proteins such as TDP-43, whose dysfunction can cause Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. FMRP can inhibit protein translation of target mRNAs that are involved in neuron plasticity, the balance between sensitization and desensitization responding to neuron activity. Therefore, FMRP-modulated protein concentration may be critical for normal neuronal function and sensitive to gene dosage. The statistically significant overlap between 5-hmC and FMRP target genes suggests that 5-hmC may contribute to proper brain function and development via epigenetic regulation of these gene transcription activities.
For example, we see a dramatic decrease of 5-hmC levels in the FMRP target gene MAP1B, which encodes a protein that belongs to the microtubule-associated protein family. MAP1B protein is involved in microtubule assembly, which is an essential step for neurogenesis. Still, the molecular mechanism remains to be determined. We found that DhMRs between the fetus and the adult are associated more with genes. Moreover, we also found that 5-hmC changes are statistically significantly associated with autism candidate genes, including several well-characterized autism candidate genes such as SHANK3, NLGN3 and TSC2. FMRP targets and ASD genes can be grouped into several functional categories, such as synaptic cell adhesion molecules, the NMDA (N-methyl-D-aspartate) receptor complex, and the mTOR pathway, most of which are associated with synaptic functions (32, 46) . Notably, synaptic dysfunction is critical to the development of autistic features and intellectual disabilities. Our observations suggest that aberrant DNA hydroxymethylation of these genes may potentially contribute to the etiology of autism and related neurodevelopmental disorders. TET1 is known to be involved in neuronal activity-induced DNA demethylation and subsequent gene expression in mouse brain (9) , suggesting that 5-hmC dynamics may be regulated by TET1 during cerebellum development.
In summary, we profiled the genome-wide distribution of 5-hmC during the development of human brain. Our results indicate that 5-hmC levels increase during cerebellum development, which could contribute to proper brain function and development. Most importantly, we found that DhMRs preferentially locate in FMRP target genes and ASD genes, implying that abnormal alteration of 5-hmC may contribute to neurodevelopmental disorders.
MATERIALS AND METHODS
Cerebellum DNA sample preparation
The fetal cerebellum DNA sample was from The State Key Laboratory of Medical Genetics, Hunan, China. The female and male adult cerebellum samples were from The Emory Alzheimer's Disease Research Center. Genomic DNA was purified by Proteinase K digestion (0.667 g/l Proteinase K in 10 mM Tris -HCl, pH 8.5, 5 mM EDTA, 0.2% SDS and 200 mM NaCl, overnight at 558C) followed by extraction with an equal volume of (25:24:1) phenol:chloroform:isoamyl alcohol saturated with 10 mM Tris-HCl, pH 8.0 and 1 mM EDTA. Purified genomic DNA was precipitated with an equal volume of isopropanol and resuspended in 10 mM Tris-HCl, pH 8.0.
5-hmC dot blot and capture
5-hmC dot-blot was performed as described previously (22) . The primary antibody used is anti-5-hmC antibody (1:10 000, #39769, Active Motif). For 5-hmC capture, genomic DNA was sonicated into 200 bp size by Misonix 3000 (microtip, 4 pulses, 27 s each, 1 min rest, power output 2, on ice). The fragment size was verified by agarose gel electrophoresis. The following 5-hmC capture steps were performed as described previously (21) .
Next generation sequencing of 5-hmC-enriched DNA 5-hmC captured libraries were generated by the NEBNext ChIP-Seq Library Prep Reagent Set for Illumina according to the manufacturer's protocol. Briefly, 25 ng of input genomic DNA or 5-hmC-captured DNA were used. DNA fragments between 150 and 300 bp were gel-purified after the adapter ligation step. PCR-amplified DNA libraries were quantified on an Agilent 2100 Bioanalyzer and diluted to 6-8 pM for subsequent cluster generation and sequencing. We performed 38-cycle single-end sequencing using version 4 Cluster Generation and sequencing kits and version 7.0 recipes. Image processing and sequence extraction were done using the standard Illumina Genome Analyzer software and pipelines developed in house at the Department of Human Genetics, Emory University.
Sequence alignment and peak identification
Human FASTQ sequence files were aligned to human (NCBI36, hg18) references using Bowtie 0.12.6 with no more than two mismatches within the first 25 bp (47). After alignment, a custom computational pipeline was used to retain only non-duplicate unique genomic matches. 5-hmC enrichment peaks were determined using a model-based analysis of ChIP-Seq (MACS) against genomic DNA input. Parameters used for analysis were: effective genome size ¼ 2.7e + 09; tag size ¼ 38; bandwidth ¼ 200; P-value cutoff ¼ 1.00e -05.
DhMR identification and annotation
To identify fetus-and adult-specific DhMRs in human brain, we employed a Poisson-based peak identification algorithm (MACS) using aligned 5-hmC-enriched tags. DhMRs were determined among all pairs of 5-hmC-enriched samples by directly comparing one sample with another in each direction. Parameters used were: effective genome size ¼ 2.7e + 09; tag size ¼ 38; bandwidth ¼ 200; P-value cutoff ¼ 1.00e -08.
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The association of DhMRs with genomic features was achieved by overlapping defined sets of DhMRs with known genomic features obtained from UCSC tables for NCBI36/ hg18: RefSeq Whole Gene, 5 ′ UTR, Exon, Intron, 3 ′ UTR, +500 bp of TSS, RefSeq Intergenic, CpG islands, and CpG island shores (+2 kb of CpG islands). DhMRs were assigned to a given genomic feature if overlapping ≥1 bp. In order to determine the fold change from expected values, the percentage of total DhMRs within a defined set was divided by the percentage expected to overlap each genomic feature by chance, based on the percentage of genomic space occupied by that genomic feature. All the statistical analysis and data processing were performed using R (http://www.r-project.org/).
FMRP target genes were obtained from Darnell et al. by HITS-CLIP experiment (32) . TDP-43 target genes were obtained from Polymenidou et al. by HITS-CLIP experiment (48) . Autism-related genes were obtained from the SFARI database of autism candidate genes (http://gene.sfari.org). Lists of highly, moderately or weakly expressed genes were generated according to human cerebellum RNA-Seq data in BrainSpan: Atlas of the Developing Human Brain database (http://www.brainspan.org/).
Gene ontology (GO) analysis
GO analyses were performed as previously described using the DAVID Bioinformatics Resources 6.7 Functional Annotation Tool (49) . Gene sets were identified by joining subsets of DhMRs with RefSeq tables obtained from the UCSC genome browser tables.
